Do analysts rate SRTS or ZJYL?

Sensus Healthcare currently has a consensus target price of $5.83, indicating a potential upside of 78.94%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, research analysts plainly believe Sensus Healthcare is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, SRTS or ZJYL?

Jin Medical International has lower revenue, but higher earnings than Sensus Healthcare. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sensus Healthcare $27.48M 1.95 -$7.72M -$0.94 N/A Jin Medical International $20.69M 8.15 $1.19M N/A N/A

Is SRTS or PDEX more profitable?

Pro-Dex has a net margin of 16.08% compared to Sensus Healthcare's net margin of -88.45%. Pro-Dex's return on equity of 22.78% beat Sensus Healthcare's return on equity. Company Net Margins Return on Equity Return on Assets Sensus Healthcare -88.45% -21.57% -19.20% Pro-Dex 16.08% 22.78% 14.30%

Does the media refer more to SRTS or PDEX?

In the previous week, Sensus Healthcare had 9 more articles in the media than Pro-Dex. MarketBeat recorded 11 mentions for Sensus Healthcare and 2 mentions for Pro-Dex. Sensus Healthcare's average media sentiment score of 1.58 beat Pro-Dex's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensus Healthcare 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Pro-Dex 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CNXU or SRTS?

In the previous week, Sensus Healthcare had 9 more articles in the media than Conexeu Sciences. MarketBeat recorded 11 mentions for Sensus Healthcare and 2 mentions for Conexeu Sciences. Sensus Healthcare's average media sentiment score of 1.58 beat Conexeu Sciences' score of 0.80 indicating that Sensus Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sensus Healthcare 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer FOCL or SRTS?

In the previous week, Sensus Healthcare had 9 more articles in the media than FocalTherics. MarketBeat recorded 11 mentions for Sensus Healthcare and 2 mentions for FocalTherics. Sensus Healthcare's average media sentiment score of 1.58 beat FocalTherics' score of 0.67 indicating that Sensus Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FocalTherics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sensus Healthcare 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Is OWLT or SRTS more profitable?

Owlet has a net margin of -8.61% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% Sensus Healthcare -88.45% -21.57% -19.20%

Sensus Healthcare (SRTS) Competitors

$3.26 +0.01 (+0.31%)

As of 09/3/2026 04:00 PM Eastern

Compare

SRTS vs. ZJYL, PDEX, CNXU, FOCL, and OWLT

Should you buy Sensus Healthcare stock or one of its competitors? Sensus Healthcare's main competitors and comparable companies include Jin Medical International (ZJYL), Pro-Dex (PDEX), Conexeu Sciences (CNXU), FocalTherics (FOCL), and Owlet (OWLT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sensus Healthcare compare to Jin Medical International?

Sensus Healthcare (NASDAQ:SRTS) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

Sensus Healthcare has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.31, meaning that its stock price is 631% more volatile than the broader market.

Sensus Healthcare currently has a consensus target price of $5.83, indicating a potential upside of 78.94%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, research analysts plainly believe Sensus Healthcare is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jin Medical International has lower revenue, but higher earnings than Sensus Healthcare.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	1.95	-$7.72M	-$0.94	N/A
Jin Medical International	$20.69M	8.15	$1.19M	N/A	N/A

Jin Medical International has a net margin of 0.00% compared to Sensus Healthcare's net margin of -88.45%. Jin Medical International's return on equity of 0.00% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-21.57%	-19.20%
Jin Medical International	N/A	N/A	N/A

In the previous week, Sensus Healthcare had 11 more articles in the media than Jin Medical International. MarketBeat recorded 11 mentions for Sensus Healthcare and 0 mentions for Jin Medical International. Sensus Healthcare's average media sentiment score of 1.58 beat Jin Medical International's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Sensus Healthcare	Very Positive
Jin Medical International	Neutral

25.3% of Sensus Healthcare shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Sensus Healthcare beats Jin Medical International on 8 of the 14 factors compared between the two stocks.

How does Sensus Healthcare compare to Pro-Dex?

Sensus Healthcare (NASDAQ:SRTS) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Pro-Dex has a net margin of 16.08% compared to Sensus Healthcare's net margin of -88.45%. Pro-Dex's return on equity of 22.78% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-21.57%	-19.20%
Pro-Dex	16.08%	22.78%	14.30%

In the previous week, Sensus Healthcare had 9 more articles in the media than Pro-Dex. MarketBeat recorded 11 mentions for Sensus Healthcare and 2 mentions for Pro-Dex. Sensus Healthcare's average media sentiment score of 1.58 beat Pro-Dex's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sensus Healthcare	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Pro-Dex	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by company insiders. Comparatively, 45.9% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Sensus Healthcare has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.06, indicating that its stock price is 94% less volatile than the broader market.

Sensus Healthcare presently has a consensus price target of $5.83, indicating a potential upside of 78.94%. Pro-Dex has a consensus price target of $70.00, indicating a potential upside of 13.36%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Sensus Healthcare is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Pro-Dex	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Pro-Dex has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	1.95	-$7.72M	-$0.94	N/A
Pro-Dex	$66.59M	2.96	$8.98M	$3.62	17.06

Summary

Pro-Dex beats Sensus Healthcare on 9 of the 16 factors compared between the two stocks.

How does Sensus Healthcare compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

25.3% of Sensus Healthcare shares are owned by institutional investors. 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Sensus Healthcare had 9 more articles in the media than Conexeu Sciences. MarketBeat recorded 11 mentions for Sensus Healthcare and 2 mentions for Conexeu Sciences. Sensus Healthcare's average media sentiment score of 1.58 beat Conexeu Sciences' score of 0.80 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sensus Healthcare	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Conexeu Sciences has a net margin of 0.00% compared to Sensus Healthcare's net margin of -88.45%. Conexeu Sciences' return on equity of 0.00% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Sensus Healthcare	-88.45%	-21.57%	-19.20%

Conexeu Sciences presently has a consensus target price of $20.00, indicating a potential upside of 279.51%. Sensus Healthcare has a consensus target price of $5.83, indicating a potential upside of 78.94%. Given Conexeu Sciences' higher possible upside, research analysts clearly believe Conexeu Sciences is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Conexeu Sciences has higher earnings, but lower revenue than Sensus Healthcare. Conexeu Sciences is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A
Sensus Healthcare	$27.48M	1.95	-$7.72M	-$0.94	N/A

Summary

Sensus Healthcare beats Conexeu Sciences on 8 of the 14 factors compared between the two stocks.

How does Sensus Healthcare compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

FocalTherics has a beta of -0.07, suggesting that its share price is 107% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.13, suggesting that its share price is 13% more volatile than the broader market.

Sensus Healthcare has lower revenue, but higher earnings than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	2.22	-$29.25M	-$1.03	N/A
Sensus Healthcare	$27.48M	1.95	-$7.72M	-$0.94	N/A

62.7% of FocalTherics shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 10.1% of FocalTherics shares are owned by insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Sensus Healthcare had 9 more articles in the media than FocalTherics. MarketBeat recorded 11 mentions for Sensus Healthcare and 2 mentions for FocalTherics. Sensus Healthcare's average media sentiment score of 1.58 beat FocalTherics' score of 0.67 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FocalTherics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sensus Healthcare	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

FocalTherics has a net margin of -56.26% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-56.26%	-248.00%	-44.69%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

FocalTherics presently has a consensus target price of $7.75, suggesting a potential upside of 85.85%. Sensus Healthcare has a consensus target price of $5.83, suggesting a potential upside of 78.94%. Given FocalTherics' higher possible upside, research analysts plainly believe FocalTherics is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Sensus Healthcare beats FocalTherics on 11 of the 17 factors compared between the two stocks.

How does Sensus Healthcare compare to Owlet?

Owlet (NYSE:OWLT) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

In the previous week, Sensus Healthcare had 11 more articles in the media than Owlet. MarketBeat recorded 11 mentions for Sensus Healthcare and 0 mentions for Owlet. Sensus Healthcare's average media sentiment score of 1.58 beat Owlet's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Owlet	Neutral
Sensus Healthcare	Very Positive

Owlet currently has a consensus price target of $15.00, indicating a potential upside of 198.80%. Sensus Healthcare has a consensus price target of $5.83, indicating a potential upside of 78.94%. Given Owlet's higher possible upside, equities analysts plainly believe Owlet is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Owlet has a net margin of -8.61% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

72.6% of Owlet shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 36.2% of Owlet shares are held by insiders. Comparatively, 10.2% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Owlet has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market.

Sensus Healthcare has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.39	-$39.68M	-$0.75	N/A
Sensus Healthcare	$27.48M	1.95	-$7.72M	-$0.94	N/A

Summary

Owlet and Sensus Healthcare tied by winning 8 of the 16 factors compared between the two stocks.

Get Sensus Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRTS vs. The Competition

Export

Metric	Sensus Healthcare	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$53.50M	$5.81B	$7.26B	$12.73B
Dividend Yield	N/A	1.76%	2.53%	8.86%
P/E Ratio	-3.47	25.93	273.28	25.38
Price / Sales	1.95	73.29	613.48	92.60
Price / Cash	N/A	33.14	77.82	52.26
Price / Book	1.46	6.04	12.89	6.14
Net Income	-$7.72M	$150.03M	$3.47B	$349.01M
7 Day Performance	-7.39%	-1.30%	0.61%	-0.27%
1 Month Performance	9.76%	1.29%	5.73%	0.68%
1 Year Performance	2.52%	9.89%	25.37%	14.84%

Sensus Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRTS Sensus Healthcare	3.3991 of 5 stars	$3.26 +0.3%	$5.83 +78.9%	+0.3%	$53.50M	$27.48M	N/A	40	Positive News
ZJYL Jin Medical International	N/A	$2.79 -8.4%	N/A	-83.4%	$218.43M	$20.69M	N/A	245	Gap Up
PDEX Pro-Dex	1.3069 of 5 stars	$64.40 -3.7%	$70.00 +8.7%	+32.9%	$205.43M	$66.59M	17.79	140	News Coverage Earnings Report
CNXU Conexeu Sciences	3.5436 of 5 stars	$7.59 -2.8%	$20.00 +163.4%	N/A	$200.86M	N/A	N/A	4
FOCL FocalTherics	4.3387 of 5 stars	$4.43 +6.0%	$7.75 +74.9%	N/A	$166.26M	$70.53M	N/A	230

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRTS) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sensus Healthcare (SRTS) Competitors

SRTS vs. ZJYL, PDEX, CNXU, FOCL, and OWLT

How does Sensus Healthcare compare to Jin Medical International?

Summary

How does Sensus Healthcare compare to Pro-Dex?

Summary

How does Sensus Healthcare compare to Conexeu Sciences?

Summary

How does Sensus Healthcare compare to FocalTherics?

Summary

How does Sensus Healthcare compare to Owlet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sensus Healthcare (SRTS) Competitors

SRTS vs. ZJYL, PDEX, CNXU, FOCL, and OWLT

How does Sensus Healthcare compare to Jin Medical International?

Which has more risk and volatility, SRTS or ZJYL?

Do analysts rate SRTS or ZJYL?

Which has higher valuation & earnings, SRTS or ZJYL?

Is SRTS or ZJYL more profitable?

Does the media refer more to SRTS or ZJYL?

Do institutionals and insiders believe in SRTS or ZJYL?

Summary

How does Sensus Healthcare compare to Pro-Dex?

Is SRTS or PDEX more profitable?

Does the media refer more to SRTS or PDEX?

Do insiders and institutionals believe in SRTS or PDEX?

Which has more risk & volatility, SRTS or PDEX?

Do analysts prefer SRTS or PDEX?

Which has better earnings and valuation, SRTS or PDEX?

Summary

How does Sensus Healthcare compare to Conexeu Sciences?

Do insiders and institutionals believe in CNXU or SRTS?

Does the media refer more to CNXU or SRTS?

Is CNXU or SRTS more profitable?

Do analysts recommend CNXU or SRTS?

Which has better earnings & valuation, CNXU or SRTS?

Summary

How does Sensus Healthcare compare to FocalTherics?

Which has more risk and volatility, FOCL or SRTS?

Which has higher valuation & earnings, FOCL or SRTS?

Do institutionals and insiders hold more shares of FOCL or SRTS?

Does the media prefer FOCL or SRTS?

Is FOCL or SRTS more profitable?

Do analysts rate FOCL or SRTS?

Summary

How does Sensus Healthcare compare to Owlet?

Does the media prefer OWLT or SRTS?

Do analysts rate OWLT or SRTS?

Is OWLT or SRTS more profitable?

Do institutionals & insiders believe in OWLT or SRTS?

Which has more risk & volatility, OWLT or SRTS?

Which has stronger valuation & earnings, OWLT or SRTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools